Sébastien Simoncelli
@ssimoncellimwtc.bsky.social
I help life sciences founders to generate more impactful opportunities on Bluesky.
Founder’s Checklist: 5 Things to Post This Month
Not sure what to post? Try this:
• Milestone update
• Personal lesson
• Industry take
• Team spotlight
• Science explainer
That’s your starter kit.
#FounderTips
#Biotech
#LifeSciences
Not sure what to post? Try this:
• Milestone update
• Personal lesson
• Industry take
• Team spotlight
• Science explainer
That’s your starter kit.
#FounderTips
#Biotech
#LifeSciences
August 22, 2025 at 12:02 PM
Founder’s Checklist: 5 Things to Post This Month
Not sure what to post? Try this:
• Milestone update
• Personal lesson
• Industry take
• Team spotlight
• Science explainer
That’s your starter kit.
#FounderTips
#Biotech
#LifeSciences
Not sure what to post? Try this:
• Milestone update
• Personal lesson
• Industry take
• Team spotlight
• Science explainer
That’s your starter kit.
#FounderTips
#Biotech
#LifeSciences
Bluesky Engagement & Science Communication
Less noise.
More curiosity.
That’s Bluesky.
Founders here can have real convos about science, policy, and innovation, without fighting the algorithm.
#ScienceComms
#Biotech
#Bluesky
Less noise.
More curiosity.
That’s Bluesky.
Founders here can have real convos about science, policy, and innovation, without fighting the algorithm.
#ScienceComms
#Biotech
#Bluesky
August 22, 2025 at 7:02 AM
Bluesky Engagement & Science Communication
Less noise.
More curiosity.
That’s Bluesky.
Founders here can have real convos about science, policy, and innovation, without fighting the algorithm.
#ScienceComms
#Biotech
#Bluesky
Less noise.
More curiosity.
That’s Bluesky.
Founders here can have real convos about science, policy, and innovation, without fighting the algorithm.
#ScienceComms
#Biotech
#Bluesky
Breaking Down Regulatory Wins
IND clearance? Great.
But don’t just post the acronym.
Explain it: what happened, why it matters, and what’s next.
That’s how you pull people in.
#Biotech
#Regulatory
#ScienceComms
IND clearance? Great.
But don’t just post the acronym.
Explain it: what happened, why it matters, and what’s next.
That’s how you pull people in.
#Biotech
#Regulatory
#ScienceComms
August 21, 2025 at 12:02 PM
Breaking Down Regulatory Wins
IND clearance? Great.
But don’t just post the acronym.
Explain it: what happened, why it matters, and what’s next.
That’s how you pull people in.
#Biotech
#Regulatory
#ScienceComms
IND clearance? Great.
But don’t just post the acronym.
Explain it: what happened, why it matters, and what’s next.
That’s how you pull people in.
#Biotech
#Regulatory
#ScienceComms
Why Bluesky is Perfect for Life Sciences Thought Leadership?
Small platform = big chance.
On Bluesky, your insights aren’t buried.
Share industry takes, R&D lessons, and founder thoughts now.
Shape the convo early.
#Biotech
#LifeSciences
#ThoughtLeadership
Small platform = big chance.
On Bluesky, your insights aren’t buried.
Share industry takes, R&D lessons, and founder thoughts now.
Shape the convo early.
#Biotech
#LifeSciences
#ThoughtLeadership
August 21, 2025 at 7:02 AM
Why Bluesky is Perfect for Life Sciences Thought Leadership?
Small platform = big chance.
On Bluesky, your insights aren’t buried.
Share industry takes, R&D lessons, and founder thoughts now.
Shape the convo early.
#Biotech
#LifeSciences
#ThoughtLeadership
Small platform = big chance.
On Bluesky, your insights aren’t buried.
Share industry takes, R&D lessons, and founder thoughts now.
Shape the convo early.
#Biotech
#LifeSciences
#ThoughtLeadership
Funding News Isn’t Enough.
“We raised $10M” gets a like.
“We raised $10M to make treatments faster for patients” gets remembered.
Funding is a story.
Make people care.
#BiotechFunding
#Startups
#LifeSciences
“We raised $10M” gets a like.
“We raised $10M to make treatments faster for patients” gets remembered.
Funding is a story.
Make people care.
#BiotechFunding
#Startups
#LifeSciences
August 20, 2025 at 12:02 PM
Funding News Isn’t Enough.
“We raised $10M” gets a like.
“We raised $10M to make treatments faster for patients” gets remembered.
Funding is a story.
Make people care.
#BiotechFunding
#Startups
#LifeSciences
“We raised $10M” gets a like.
“We raised $10M to make treatments faster for patients” gets remembered.
Funding is a story.
Make people care.
#BiotechFunding
#Startups
#LifeSciences
What Bluesky Teaches Founders About Trust?
Trust is built when you share wins and lessons.
Don’t just post polished updates.
Show the pivots, the struggles, the reality.
That’s what sticks here.
#FounderJourney
#Biotech
#Transparency
Trust is built when you share wins and lessons.
Don’t just post polished updates.
Show the pivots, the struggles, the reality.
That’s what sticks here.
#FounderJourney
#Biotech
#Transparency
August 20, 2025 at 7:02 AM
What Bluesky Teaches Founders About Trust?
Trust is built when you share wins and lessons.
Don’t just post polished updates.
Show the pivots, the struggles, the reality.
That’s what sticks here.
#FounderJourney
#Biotech
#Transparency
Trust is built when you share wins and lessons.
Don’t just post polished updates.
Show the pivots, the struggles, the reality.
That’s what sticks here.
#FounderJourney
#Biotech
#Transparency
Way to Make Complex Science Engaging
Try this:
❌ “85% efficacy in murine models.”
✅ “Strong results in mice bring us closer to patient trials.”
Clear beats clever.
Every time.
#ScienceComms
#BiotechStartups
#LifeSciences
Try this:
❌ “85% efficacy in murine models.”
✅ “Strong results in mice bring us closer to patient trials.”
Clear beats clever.
Every time.
#ScienceComms
#BiotechStartups
#LifeSciences
August 19, 2025 at 12:03 PM
Way to Make Complex Science Engaging
Try this:
❌ “85% efficacy in murine models.”
✅ “Strong results in mice bring us closer to patient trials.”
Clear beats clever.
Every time.
#ScienceComms
#BiotechStartups
#LifeSciences
Try this:
❌ “85% efficacy in murine models.”
✅ “Strong results in mice bring us closer to patient trials.”
Clear beats clever.
Every time.
#ScienceComms
#BiotechStartups
#LifeSciences
How to Share Clinical Milestones on Bluesky
“Phase 1 complete” is boring.
Tell a story: why it matters for patients, what’s next for your team, and why the field should care.
Milestones are stories, not bullet points.
#ClinicalTrials
#Biotech
#ScienceComms
“Phase 1 complete” is boring.
Tell a story: why it matters for patients, what’s next for your team, and why the field should care.
Milestones are stories, not bullet points.
#ClinicalTrials
#Biotech
#ScienceComms
August 19, 2025 at 7:14 AM
How to Share Clinical Milestones on Bluesky
“Phase 1 complete” is boring.
Tell a story: why it matters for patients, what’s next for your team, and why the field should care.
Milestones are stories, not bullet points.
#ClinicalTrials
#Biotech
#ScienceComms
“Phase 1 complete” is boring.
Tell a story: why it matters for patients, what’s next for your team, and why the field should care.
Milestones are stories, not bullet points.
#ClinicalTrials
#Biotech
#ScienceComms
Bluesky vs LinkedIn: Where Should Founders Focus?
LinkedIn = reach & investors.
Bluesky = early adopters & authentic convos.
Smart founders play both.
Build trust here, visibility there.
#StartupStrategy
#BiotechFounders
#Bluesky
LinkedIn = reach & investors.
Bluesky = early adopters & authentic convos.
Smart founders play both.
Build trust here, visibility there.
#StartupStrategy
#BiotechFounders
#Bluesky
August 18, 2025 at 12:02 PM
Bluesky vs LinkedIn: Where Should Founders Focus?
LinkedIn = reach & investors.
Bluesky = early adopters & authentic convos.
Smart founders play both.
Build trust here, visibility there.
#StartupStrategy
#BiotechFounders
#Bluesky
LinkedIn = reach & investors.
Bluesky = early adopters & authentic convos.
Smart founders play both.
Build trust here, visibility there.
#StartupStrategy
#BiotechFounders
#Bluesky
Why Founders Struggle with Translating Science to Social Media?
Your research won’t reach people if it reads like a paper.
Strip out the jargon.
Clarity wins attention, not complexity.
On Bluesky, founders who simplify win.
#LifeSciences
#ScienceComms
#Biotech
Your research won’t reach people if it reads like a paper.
Strip out the jargon.
Clarity wins attention, not complexity.
On Bluesky, founders who simplify win.
#LifeSciences
#ScienceComms
#Biotech
August 18, 2025 at 7:02 AM
Why Founders Struggle with Translating Science to Social Media?
Your research won’t reach people if it reads like a paper.
Strip out the jargon.
Clarity wins attention, not complexity.
On Bluesky, founders who simplify win.
#LifeSciences
#ScienceComms
#Biotech
Your research won’t reach people if it reads like a paper.
Strip out the jargon.
Clarity wins attention, not complexity.
On Bluesky, founders who simplify win.
#LifeSciences
#ScienceComms
#Biotech
Imagine pitching your company without any slides.
Just story, relevance, clarity.
Could you do it?
#pitchpractice
#foundermindset
#biotechclarity
Just story, relevance, clarity.
Could you do it?
#pitchpractice
#foundermindset
#biotechclarity
August 1, 2025 at 4:00 PM
Imagine pitching your company without any slides.
Just story, relevance, clarity.
Could you do it?
#pitchpractice
#foundermindset
#biotechclarity
Just story, relevance, clarity.
Could you do it?
#pitchpractice
#foundermindset
#biotechclarity
You don’t need more likes.
You need more people DMing you saying: “That post made me think.”
Optimise for impact, not applause.
#contentstrategy
#biotechfounders
#socialselling
You need more people DMing you saying: “That post made me think.”
Optimise for impact, not applause.
#contentstrategy
#biotechfounders
#socialselling
August 1, 2025 at 10:02 AM
You don’t need more likes.
You need more people DMing you saying: “That post made me think.”
Optimise for impact, not applause.
#contentstrategy
#biotechfounders
#socialselling
You need more people DMing you saying: “That post made me think.”
Optimise for impact, not applause.
#contentstrategy
#biotechfounders
#socialselling
Founders who wait for 'traction' to start posting will miss the people who could’ve helped build it.
Visibility is a growth lever.
#lifesciencemarketing
#earlystagebiotech
#foundertips
Visibility is a growth lever.
#lifesciencemarketing
#earlystagebiotech
#foundertips
July 31, 2025 at 4:02 PM
Founders who wait for 'traction' to start posting will miss the people who could’ve helped build it.
Visibility is a growth lever.
#lifesciencemarketing
#earlystagebiotech
#foundertips
Visibility is a growth lever.
#lifesciencemarketing
#earlystagebiotech
#foundertips
Biotech isn’t boring.
But the way most founders explain it is.
If your post wouldn’t make a curious 16-year-old stop scrolling, try again.
#biotechedge
#founderbranding
#communicationskill
But the way most founders explain it is.
If your post wouldn’t make a curious 16-year-old stop scrolling, try again.
#biotechedge
#founderbranding
#communicationskill
July 31, 2025 at 10:02 AM
Biotech isn’t boring.
But the way most founders explain it is.
If your post wouldn’t make a curious 16-year-old stop scrolling, try again.
#biotechedge
#founderbranding
#communicationskill
But the way most founders explain it is.
If your post wouldn’t make a curious 16-year-old stop scrolling, try again.
#biotechedge
#founderbranding
#communicationskill
Your target audience doesn’t care about your PhD.
They care if you can solve their $10M problem.
Talk to their priorities, not your credentials.
#lifesciencebiz
#founderinsight
#biotechgrowth
They care if you can solve their $10M problem.
Talk to their priorities, not your credentials.
#lifesciencebiz
#founderinsight
#biotechgrowth
July 30, 2025 at 4:02 PM
Your target audience doesn’t care about your PhD.
They care if you can solve their $10M problem.
Talk to their priorities, not your credentials.
#lifesciencebiz
#founderinsight
#biotechgrowth
They care if you can solve their $10M problem.
Talk to their priorities, not your credentials.
#lifesciencebiz
#founderinsight
#biotechgrowth
If your drug delivery platform is groundbreaking, why is your content invisible?
Start by answering what only your tech can answer.
#drugdelivery
#biotechfounders
#lifesciencestrategy
Start by answering what only your tech can answer.
#drugdelivery
#biotechfounders
#lifesciencestrategy
July 30, 2025 at 10:02 AM
If your drug delivery platform is groundbreaking, why is your content invisible?
Start by answering what only your tech can answer.
#drugdelivery
#biotechfounders
#lifesciencestrategy
Start by answering what only your tech can answer.
#drugdelivery
#biotechfounders
#lifesciencestrategy
Why do most 'innovative' biotech pitches still look like they were written for a 2004 VC deck? Innovation starts with how you tell the story.
#biotechmarketing
#founderbranding
#lifescience
#biotechmarketing
#founderbranding
#lifescience
July 29, 2025 at 4:03 PM
Why do most 'innovative' biotech pitches still look like they were written for a 2004 VC deck? Innovation starts with how you tell the story.
#biotechmarketing
#founderbranding
#lifescience
#biotechmarketing
#founderbranding
#lifescience
Biotech founders avoid talking about failure.
But your next partner might be more interested in your last mistake than your last milestone.
What did you learn the hard way?
#biotech
#lifesciencefounder
#sciencetalk
But your next partner might be more interested in your last mistake than your last milestone.
What did you learn the hard way?
#biotech
#lifesciencefounder
#sciencetalk
July 29, 2025 at 10:03 AM
Biotech founders avoid talking about failure.
But your next partner might be more interested in your last mistake than your last milestone.
What did you learn the hard way?
#biotech
#lifesciencefounder
#sciencetalk
But your next partner might be more interested in your last mistake than your last milestone.
What did you learn the hard way?
#biotech
#lifesciencefounder
#sciencetalk
Most founders ghost their audience between funding rounds.
Then wonder why their next announcement gets ignored.
In science, consistency builds credibility. Why forget that online?
#StartupVisibility
#FounderMarketing
#LifeScienceGrowth
Then wonder why their next announcement gets ignored.
In science, consistency builds credibility. Why forget that online?
#StartupVisibility
#FounderMarketing
#LifeScienceGrowth
July 25, 2025 at 4:02 PM
Most founders ghost their audience between funding rounds.
Then wonder why their next announcement gets ignored.
In science, consistency builds credibility. Why forget that online?
#StartupVisibility
#FounderMarketing
#LifeScienceGrowth
Then wonder why their next announcement gets ignored.
In science, consistency builds credibility. Why forget that online?
#StartupVisibility
#FounderMarketing
#LifeScienceGrowth
LinkedIn is full of scientists trying to write like marketers.
What if founders did the opposite?
What would it look like if marketers started writing like scientists?
#SciComm
#LifeScienceBranding
#ContentStrategy
What if founders did the opposite?
What would it look like if marketers started writing like scientists?
#SciComm
#LifeScienceBranding
#ContentStrategy
July 24, 2025 at 4:02 PM
LinkedIn is full of scientists trying to write like marketers.
What if founders did the opposite?
What would it look like if marketers started writing like scientists?
#SciComm
#LifeScienceBranding
#ContentStrategy
What if founders did the opposite?
What would it look like if marketers started writing like scientists?
#SciComm
#LifeScienceBranding
#ContentStrategy
Why are so many biotech websites still unreadable on mobile?
You raised $30M, but your About page still says 'leveraging synergies' and takes 12 seconds to load.
Who’s responsible for fixing this?
#BiotechMarketing
#UXfail
#FoundersView
You raised $30M, but your About page still says 'leveraging synergies' and takes 12 seconds to load.
Who’s responsible for fixing this?
#BiotechMarketing
#UXfail
#FoundersView
July 23, 2025 at 4:02 PM
Why are so many biotech websites still unreadable on mobile?
You raised $30M, but your About page still says 'leveraging synergies' and takes 12 seconds to load.
Who’s responsible for fixing this?
#BiotechMarketing
#UXfail
#FoundersView
You raised $30M, but your About page still says 'leveraging synergies' and takes 12 seconds to load.
Who’s responsible for fixing this?
#BiotechMarketing
#UXfail
#FoundersView
AI won’t replace scientists.
But founders who ignore AI will be replaced by those who don’t.
What’s the most underrated AI tool in your stack right now?
#AIinScience
#LifeScienceFounders
#BiotechFuture
But founders who ignore AI will be replaced by those who don’t.
What’s the most underrated AI tool in your stack right now?
#AIinScience
#LifeScienceFounders
#BiotechFuture
July 22, 2025 at 4:02 PM
AI won’t replace scientists.
But founders who ignore AI will be replaced by those who don’t.
What’s the most underrated AI tool in your stack right now?
#AIinScience
#LifeScienceFounders
#BiotechFuture
But founders who ignore AI will be replaced by those who don’t.
What’s the most underrated AI tool in your stack right now?
#AIinScience
#LifeScienceFounders
#BiotechFuture
Most life science founders obsess over visibility.
↳ But what if visibility is the wrong KPI?
↳ What if memorability builds trust faster than reach ever could?
↳ What are you doing to be unforgettable?
#LifeScience
#BiotechBranding
#FounderTips
↳ But what if visibility is the wrong KPI?
↳ What if memorability builds trust faster than reach ever could?
↳ What are you doing to be unforgettable?
#LifeScience
#BiotechBranding
#FounderTips
July 21, 2025 at 4:02 PM
Most life science founders obsess over visibility.
↳ But what if visibility is the wrong KPI?
↳ What if memorability builds trust faster than reach ever could?
↳ What are you doing to be unforgettable?
#LifeScience
#BiotechBranding
#FounderTips
↳ But what if visibility is the wrong KPI?
↳ What if memorability builds trust faster than reach ever could?
↳ What are you doing to be unforgettable?
#LifeScience
#BiotechBranding
#FounderTips
Want a quick overview of biotech funding in Europe this week?
12 companies raised fresh capital, across all stages.
12 companies raised fresh capital, across all stages.
July 19, 2025 at 6:09 AM
Want a quick overview of biotech funding in Europe this week?
12 companies raised fresh capital, across all stages.
12 companies raised fresh capital, across all stages.
New theory: The more complicated the molecule drawing, the less anyone in the room understands what it does.
Show me a figure that made you instantly question your career choices.
#MolConfusion
#PosterSessionSurvivor
#BiochemPain
Show me a figure that made you instantly question your career choices.
#MolConfusion
#PosterSessionSurvivor
#BiochemPain
July 18, 2025 at 4:02 PM
New theory: The more complicated the molecule drawing, the less anyone in the room understands what it does.
Show me a figure that made you instantly question your career choices.
#MolConfusion
#PosterSessionSurvivor
#BiochemPain
Show me a figure that made you instantly question your career choices.
#MolConfusion
#PosterSessionSurvivor
#BiochemPain